Literature DB >> 20688774

The axillary artery--a new approach for endovascular treatment of thoracic aortic diseases.

Eduardo Keller Saadi1, Luiz Henrique Dussin, Leandro Moura, André Severo Machado.   

Abstract

Endovascular procedures are increasing in number for the treatment of thoracic aortic diseases (TAD). Retrograde approach through the femoral artery is the preferred vascular access. Despite the improvements in the devices, femoral artery complications still occurs and some times this access is not possible because of the small size of the vessels, obstruction, calcification, dissection or extreme tortuosity. An axillary approach could be an alternative. We present a series of five patients and describe the technique we used in the axillary artery approach to treat TAD. There were two ascending aortas and three descending aortic aneurysms treated. The left axillary artery was used in three patients and the right in two. There were no local or neurological complications. In this preliminary approach, both axillary arteries were a good alternative access for endovascular graft insertion to treat aortic diseases when femoral access was not possible or was suboptimal.

Entities:  

Mesh:

Year:  2010        PMID: 20688774     DOI: 10.1510/icvts.2010.245274

Source DB:  PubMed          Journal:  Interact Cardiovasc Thorac Surg        ISSN: 1569-9285


  2 in total

1.  Use of a Steerable Sheath for Completely Femoral Access in Branched Endovascular Aortic Repair Compared to Upper Extremity Access.

Authors:  Sven R Hauck; Wolf Eilenberg; Alexander Kupferthaler; Maximilian Kern; Theresa-Marie Dachs; Alexander Wressnegger; Christoph Neumayer; Christian Loewe; Martin A Funovics
Journal:  Cardiovasc Intervent Radiol       Date:  2022-04-07       Impact factor: 2.797

2.  Creating an appropriate access for endovascular repair by replacing a dissected femoral artery in aortic dissection.

Authors:  Kimihiro Kobayashi; Tetsuro Uchida; Atsushi Yamashita; Mitsuaki Sadahiro
Journal:  Interact Cardiovasc Thorac Surg       Date:  2021-04-08
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.